GlassScriptPhysician profile
Quy V Le
NPI 1073762274
$226,994.25
in general payments reported to CMS, 2019-2025
20 companies · $8,366 in 2025
The $8,366 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111K · 2020: $42K · 2021: $18K · 2022: $30K · 2023: $14K · 2024: $4,459 · 2025: $8,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Food and Beverage: $1,606 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Food and Beverage | $1,605.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $225,534.32 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Integra Lifesciences Corporation | $254.23 | 2020-2025 | Integra, Omnigraft, Surgimend |
| Ethicon US, LLC | $237.30 | 2019-2025 | Echelon; Endopath, Dermabond Prineo, Echelon Flex |
| Tela Bio, INC. | $163.16 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $118.57 | 2019-2023 | Airseal |
| Janssen Scientific Affairs, LLC | $103.10 | 2019 | |
| Davol INC. | $94.76 | 2019-2025 | Arista, Phasix Mesh |
| Medtronic, INC. | $93.30 | 2023-2024 | Ligasure, Progrip |
| Baxter Healthcare | $68.12 | 2020-2024 | Perclot |
| Becton, Dickinson and Company | $66.79 | 2025 | Phasix Mesh |
| Astrazeneca Pharmaceuticals LP | $44.99 | 2023 | Andexxa |
| Solventum Corporation | $44.68 | 2024 | Activ.A.C., V.A.C. Granufoam, Prevena |
| Innovation Technologies INC | $30.81 | 2025 | Irrisept |
| Elucent Medical | $27.86 | 2024 | |
| Acell, INC. | $26.44 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $23.46 | 2022 | |
| Axonics, INC. | $20.71 | 2021 | |
| Hologic Sales and Service, LLC | $14.01 | 2021 | |
| Smith+Nephew, INC. | $13.89 | 2019 | |
| Merck Sharp & Dohme LLC | $13.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quy Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.